Recombinant SETD2 (1392-2564) (accession number NP_054878.5) was expressed in Sf9 cells and contains an N-terminal FLAG tag with an observed molecular weight of 134 kDa.
SETD2
Origine: Humain
Hôte: Escherichia coli (E. coli)
Recombinant
EAA
Active
Indications d'application
Recombinant SETD2 (1392-2564) is suitable for use in the study of enzyme kinetics, inhibitor screening, and selectivity profiling. Specific Activity: H3K36 methyltransferase. HMT Assay Conditions: 50 mM TrisCl, pH 8.6, 0.02 % Triton X-100, 2 mM MgCl2, 1 mM TCEP, 100 μM SAM, 30 ng/μl Recombinant Nucleosomes, 30 ng/μl Recombinant SETD2 (1392-2564) at 2 hours at room temperature. Activity was detected by fluorography.
Restrictions
For Research Use only
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
Stock
-80 °C
Stockage commentaire
Recombinant proteins in solution are temperature sensitive and must be stored at -80°C to prevent degradation.
SETD2 (SET Domain Containing 2) is a histone methyltransferase that methylates histone H3 at lysine 36. H3K36 methylation is associated with active chromatin. SETD2 also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA pol II. Recombinant SETD2 (1392-2564) includes amino acids 1392-2564 that contains the SET domain of SETD2 that catalyzes methylation of lysine residues.